BioBrit

Castle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions.

BiotechDigital HealthHealthtechFriendswood, US

DJDerek J. Maetzold(President, CEO and Director)inFSFrank Stokes(Chief Financial Officer)inKOKristen Oelschlager(Chief Operating Officer)inToby Juvenal(Chief Commercial Officer)inHillary Caruso(Chief of Staff)inTobin W. Juvenal(Chief Commercial Officer)

Co-investorsILIllumina VenturesMOMountain Group CapitalSOSofinnova HealthQuest Partners

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

STSchuetz Thomas(Executive Officer, Director)inEAErrik Anderson(Executive Officer, Director)inTJThomas J. Schuetz(Executive Officer, Director)inVBVered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)inNLNeil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsALAlumni VenturesF-F-Prime CapitalFOForesite CapitalGVGV (Google Ventures)OROrbiMedVEvenBio Partners+3 more

Geron is a biopharmaceutical company focused on developing therapies for blood cancer.

BiotechHealthtechLongevityMedical Devices

Michael D. West(Founder)HSHarout Semerjian(President and Chief Executive Officer)inMJMichelle J. Robertson(Executive Vice President, Chief Financial Officer, Treasurer and Interim Secretary)inJEJoseph Eid(Executive Vice President, Research and Development, Chief Medical Officer)inAEAhmed ElNawawi(Executive Vice President, Chief Commercial Officer)in

Co-investorsNENew Enterprise Associates (NEA)VEVenrockDODomain Associates

Ovid Therapeutics develops medicines for children and adults with epilepsies and brain conditions, focusing on anti-seizure and neurological treatments.

BiotechHealthtechMedical DevicesNew York, US

MJMatthew J. During(Executive Officer, Director)inJMJeremy M. Levin(Co-founder and Executive Chairman)inMAMeg Alexander(President & Chief Executive Officer)inCCCharles Carter(Chief Financial Officer)inVFVictoria Fort(Chief Strategy Officer)inPKPetra Kaufmann(Chief Medical Officer)in

Co-investorsSASanofi Ventures

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company that develops and commercializes small-molecule and antibody cancer therapies, including two FDA-approved medicines: revumenib (a menin inhibitor for acute leukemias) and axatilimab (a CSF-1R blocking antibody for graft-versus-host disease and fibrotic diseases), along with clinical-stage programs exploring expanded uses and combinations in oncology.

BiotechWaltham, US

John Pallies(Executive Officer)inAMArlene Morris(Executive Officer, Director)inMAMichael A. Metzger(Chief Executive Officer)inKAKeith A. Goldan(Chief Financial Officer)in

BoardDPDennis Podlesak(Director)inIvor Royston(Director)

Co-investorsAIAisling CapitalATATEM Capital FundAVAvoro Capital AdvisorsDEDelos CapitalECEcoR1 CapitalFOForesite Capital+6 more

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.

BiotechHealthtechCarlsbad, US

Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)inAlan Fuhrman(Executive Officer)inTHTodd Harris(President, Chief Executive Officer and Director)inBhavesh Ashar(Chief Operating Officer)in

Co-investorsALAlta PartnersNENextech InvestCACanaan PartnersNENEXTECH ONCOLOGY SCSPRARA Capital

BiotechSan Diego, US

Douglas J. Jolly(Founder)inCarlos E. Ibanez(Executive Officer)Robert Anthony Williamson(Director)Troy Wilson(Director)Michael Martin(Director)Nicholas A. Boyle, Ph.D.(Executive Officer, Director)

Co-investorsTATakeda Ventures

A biopharmaceutical company with over 30 years of experience developing and commercializing treatments for central nervous system (CNS) diseases.

BiotechHealthtech

Co-investorsDADag VenturesRIRidgeback Capital

Alta Partners is a venture capital firm focused on life sciences and healthcare investments, with a portfolio that has generated over 90 FDA-approved products and includes both therapeutic companies and tech-enabled patient care services.

BiotechHealthtechMedical Devices

Jean DeleageGNGuy NohrainGarrett GruenerMarino Polestra

BiotechSan Diego, US

FFFrancois Ferre(Director)MMMagda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)

Co-investorsTETelegraph Hill PartnersALAlly Bridge GroupVIVivo CapitalWUWuXi Healthcare Ventures

Alume Biosciences develops nerve illumination technology for surgery, including bevonescein (ALM-488), an injectable peptide that makes nerves glow to help surgeons identify and preserve them during procedures such as head-and-neck and prostate surgery.

BiotechHealthtechMedical DevicesLa Jolla, US

QNQuyen Nguyen(Co-founder)inRoger Tsien(Co-founder)Kaveri Parker(Executive Officer)inBBBrett Berman(Executive Officer, Director)inJSJames Schmidt(Executive Officer)in

BoardKim Kamdar(Director)

Amplo Biotechnology develops adeno-associated virus (AAV) gene therapies for genetic diseases of the neuromuscular junction, targeting rare and ultra-rare patient populations such as those with Congenital Myasthenic Syndromes.

BiotechHealthtechPompano Beach, US

Al Hawkins(President / Program Director)Jean Kim(Director)Paul Hawkins(Executive Officer, Director)Terry Vance(Director)Matthew Pauls(Director)Patricio Sepulveda(Executive Officer, Director)in

Developing a new class of antifungal medicine to overcome limitations of current therapies.

Co-investorsGOGolden SeedsKEKeiretsu ForumPAPappas CapitalSOSofinnova Ventures3X3x5 PartnersARArix Bioscience+4 more

Aspen Biosciences provides consulting, advisory, and research resources focused on drug discovery and biopharmaceutical R&D, serving pharmaceutical and biotech companies navigating program management, digital transformation, and emerging technologies like AI.

AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaSSan Diego, US

Attralus develops pan-amyloid removal (PAR) therapeutics — biologics and imaging agents designed to bind and remove toxic amyloid — to treat patients with systemic amyloidosis across all disease types and stages.

BiotechHealthtechSouth San Francisco, US

JWJonathan Wall(Executive Officer)inSpencer Guthrie(Executive Officer)MTMark Timney(Executive Officer, Director)inBenson Fong(Executive Officer)RKRahul Kakkar(Director)inGreg Bell(Executive Officer)

Co-investorsALAlpha Wave GlobalLILifeSci Venture PartnersVEvenBio PartnersJAJanus Henderson InvestorsREREDMILESASamsara BioCapital+2 more

Biolinq develops glucose-sensing technology based on micro-array biosensors for metabolic health monitoring, including continuous glucose monitoring.

BiotechDigital HealthHardwareHealthtechMedical DevicesSan Diego, US

JTJared Tangney(Co-founder)inRYRich Yang(Co-founder)inEdward Kliphuis(Director)

BoardDBDaniel Bradbury(Director)inLGLana Ghanem(Director)

Co-investorsALAlpha Wave GlobalRIRiverVest Venture PartnersABAble PartnersAPAphelion CapitalAVAverin CapitalBEBeyond Capital+7 more

Exact Sciences develops and runs laboratory tests and clinical studies for cancer detection and treatment, serving patients and health care professionals in oncology.

BiotechDigital HealthMedical DevicesSan Diego, US

Tony Broad(Executive Officer)Francois Ferre(Director)Nick Ecos(Executive Officer, Director)Joseph Markee(Executive Officer, Director)

Co-investorsMEMESA VERDE VENTURE PARTNERS

BioRock Ventures is a seed-stage venture capital fund that invests in private life science startups developing novel FDA-regulated therapeutic drugs across all disease areas and modalities.

Biotech

Co-investorsATAtacama Ventures

CardioFocus develops Pulsed Field Ablation (PFA) technologies and systems for electrophysiologists to treat complex cardiac arrhythmias with precision and control.

BiotechHealthtechMedical DevicesMarlborough, US

Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)inARAnjie Roldan(Executive Officer)inWarren R. Clark III(Executive Officer)Stephan S. Ogilvie(CEO)in

Co-investorsSASaints CapitalSVSV Health InvestorsACAccuitive Medical VenturesOXOxford Bioscience PartnersSVSV Life Sciences

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.

AI & Machine LearningBiotechDeep Tech

Co-investorsDCDCVC (Data Collective)DCDCVC BioTETenmileALAlexandriaCACasdin CapitalLULux Capital

CRISPR QC develops the CRISPR Analytics Platform, a graphene-based biosensor system that provides real-time quantitative kinetic measurements of RNP formation, DNA target binding, and CRISPR-Cas cleavage activity.

BiotechDeep TechHardwareSan Diego, US

RBRoss Bundy(Executive Officer, Director)inKiana Aran(Director)Michael Heltzen(Director)

BoardGeorge Bonaros(Director)Paul Grint(Director)Toby Richardson(Director)

Co-investorsSESerra VenturesSUSuncoast Ventures

DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing.

BiotechHealthtechMedical DevicesHighland, US

MGMary Gardner(Chief Executive Officer & Founder)inSameer B. Shah(Chief Scientist)Steven Yoelin(Chief Medical Strategist)DJDimas Jimenez(Chief Financial Advisor)

BoardDBDaniel Bradbury(Director)in

Ecor1 Capital is an investment firm with a team of professionals across portfolio management, analysis, operations, and investor relations.

BiotechDigital Health

ONOleg Nodelman(Founder + Portfolio Manager)

Encoded develops gene therapies for neurological disorders through an integrated platform approach.

BiotechSouth San Francisco, US

STStephanie Tagliatela(Founder)inKRKartik Ramamoorthi, Ph.D.(Co-founder, Chief Executive Officer & Board Member)Kartik Ramamoorthi(Founder)

Co-investorsARARCH Venture PartnersGVGV (Google Ventures)ILIllumina VenturesMEMenlo VenturesSOSoftBank Vision FundVEVenrock+2 more

Non-invasive diagnostic tools for detecting and managing chronic diseases such as diabetes.

San Diego, US

John D Gerace(Executive Officer, Director)Craig Misrach(Director)

BoardDBDan Bradbury(Director)inAndy Sassine(Director)Lynn-Ann Gries(Director)James E. Pinkin(Director)

Co-investorsBOBootstrap Venture Partners

Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records.

Digital HealthHardwareHealthtechMedical DevicesSan Diego, US

CGCary Gunn(Founder)in

Co-investorsBOBoutique Venture PartnersCLClaremont Creek VenturesCLCLI VenturesFUFusionX VenturesHBHBM Healthcare InvestmentsHBHBM Partners+7 more

Hemostemix is a clinical-stage regenerative medicine company developing ACP-01, an investigational autologous (patient-derived) stem cell therapy for vascular and ischemic conditions such as critical limb ischemia, peripheral arterial disease, ischemic cardiomyopathy, and heart failure.

BiotechHealthtechLongevityMedical DevicesBlackfalds

RBRoger Bergersen(Founder (of predecessor TheraVitae Inc.))TAThomas A. Smeenk(President & CEO, Co-Founder)inIna Sarel(VP, Research and Development)inKMKyle Makofka(Chief Restructuring Officer)inDavid Berman(Chief Financial Officer)Dr. Fraser Henderson(Chief Medical Officer)

In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience.

BiotechConsumerFoodTechHealthtechNashville, US

RLRandolph Legg(Chief Executive Officer)inSHScott Holmstrom, Ph.D.(Chief Scientific Officer)EGEric Graves(Director)Jay Ferguson(Executive Officer)Robin Readnour(Director)DHDiane Hirakawa(Director)

Co-investorsMOMountain Group Capital

Independa operates Health Hub, a HIPAA-compliant health and wellness platform for seniors that delivers telehealth, video calling, family communication, games, and fitness tools across TVs, tablets, computers, and phones.

Digital HealthHealthtechLongevitySan Diego, US

KSKian Saneii(Founder & CEO)inJaye Connolly(Executive Officer)Richard Della Penna(Executive Officer)Gary Gilmore(Executive Officer)John Carrington(Director)

BoardMagda Marquet(Director)

Co-investorsKEKeshif Ventures

Intercept Pharmaceuticals develops and commercializes treatments for rare and serious liver and other diseases, with a focus on conditions such as primary biliary cholangitis.

BiotechHealthtechMedical Devices

Co-investorsAIAisling CapitalRIRidgeback CapitalSASamsara BioCapital

MD Revolution (CoachCare) provides remote care management technology and US-based clinical care services for healthcare practices, supporting programs such as remote patient monitoring, chronic care management, and behavioral health integration.

Digital HealthHealthtechSaaSSan Diego, US

SDSamir Damani(Executive Officer, Director)inArthur Roke(Executive Officer)Pratik Patel(Executive Officer)

BoardJBJean Balgrosky(Executive Officer, Director)inGarrett Vygantas(Director)Jacqueline Kosecoff(Director)

Co-investorsBOBootstrap Venture PartnersJUJump Capital

Medical Excellence Capital is a venture capital firm investing in early-stage life science and healthcare companies.

AI & Machine LearningBiotechFintechHealthtechNew York, US

John Prufeta(Chief Executive Officer and Managing Partner)Eric Heil(Managing Partner)KKKim Kamdar(Managing Partner)Brian Halak(Managing Partner)Joni Mancini(Managing Partner)

Minutia develops insulin-producing cell transplants that can be monitored in vivo over time, aimed at improving cell replacement therapy for diabetes.

BiotechDeep TechDigital Health

Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications.

BiotechHealthtechMedical Devices

Co-investorsAVAvoro Capital AdvisorsBOBoxer Capital, LLCNENextech InvestPAPappas Capital

Mountain Group Partners is a venture capital firm with 25 years of history that invests in disruptive technologies, diagnostics, medtech, animal health, and drug development across underserved sectors.

AI & Machine LearningBiotechHealthtechMedical DevicesNashville, US

BSByron Smith(Co-founder & Managing Director)JCJoe Cook, III(Co-founder & Managing Director)RRRob Readnour(Co-founder & Managing Director)JCJoe Cook, Jr.(Co-founder & Managing Director)

Telemynd is a mental healthcare platform that connects patients with licensed providers through a human-centered approach, prioritizing privacy and continuity of care while using technology to reduce administrative burden and improve access.

Digital HealthHealthtechMental HealthAliso Viejo, US

Paul Buck(Executive Officer)GCGeorge Carpenter(Executive Officer)inPHPatrick Herguth(CEO)in

BoardZachary McAdoo(Director)Andrew Sassine(Director)John Pappajohn(Director)

Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.

BiotechConstruction TechHealthtechUK, GB

JIM CAUSEY(Executive Officer)PETER RULE(Executive Officer, Director)inPATRICK NUGENT(Executive Officer)DONALD WEBBER(Executive Officer)

BoardADITYA PURI(Director)KENNETH ABRAMOWITZ(Director)

Co-investorsASAscension VenturesSISignet Healthcare Partners

Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development.

BiotechConsumerDigital HealthFemTechHealthtechSan Diego, US

SVStephen Van Dien(Founder)inSCStephanie Culler(Founder)in

Co-investorsFIFirst Bight VenturesPRPropel Bio PartnersFIFifty YearsHEHemi Ventures, LlcOCOcampo CapitalPIPioneer+13 more

Primmune Therapeutics develops PRTX007, an orally administered, systemically active TLR7 agonist that activates interferon-associated innate immune pathways for use in cancer immunotherapy.

BiotechHealthtechCarlsbad, US

JAJames Appleman(SVP, R&D and CSO, Cofounder)PRPaulo Rangel(Chief Business Officer and Cofounder)inStephen Webber(Vice President, Medicinal Chemistry, and Cofounder)inCMCharles McDermott(President & CEO, Director)

BoardTodd J Harris(Director)in

Co-investorsBIBioRock VenturesSASamsara BioCapitalBIBioqube VenturesOBOberland CapitalPOPolaris Partners

ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

LMLarry Mimms(Executive Officer, Director)inMagda Marquet(Director)Martin Hendrix(Director)Larry Abensur(Director)Peter Westlake(Executive Officer, Director)

PTM Therapeutics is a biotechnology company developing therapeutic candidates.

BiotechMedical DevicesBedford, US

Jennifer C. Cheng(CEO/Co-Founder)TWTony W. Liang(VP of Research/Co-Founder)inCharles A. Parkos(Scientific Co-Founder)Jennifer C. Brazil(Scientific Co-Founder)

Co-investorsBIBioRock Ventures

RayBalance develops a proprietary, non-reformulation platform that treats the subcutaneous injection administration site as a delivery-performance variable to improve absorption predictability without altering a partner's drug product.

BiotechDeep TechMedical DevicesSan Diego, US

Red Tree is a life science venture capital firm using a West Coast-focused, early-stage investment strategy.

Biotech

Renova Therapeutics develops investigational gene therapies intended as single-dose, long-lasting treatments for common chronic diseases, with an initial focus on congestive heart failure and type 2 diabetes.

BiotechHealthtechCarlsbad, US

Kirk Hammond(Director)SSShawn Swaney(Executive Officer)in

BoardRoy Cosan(Director)Pierre Lecocq(Director)Vijay Mahant(Director)Michael Torres(Director)

RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments.

AI & Machine LearningBiotechLaguna Niguel, US

Devan ShahinMLMichelle Lynn Hall

Co-investorsELElmehøj VenturesPOPortal InnovationsSEService Provider Capital

Samsara BioCapital is a venture capital firm that invests in therapeutic and biotech companies, backing scientific teams developing new drugs and medical treatments.

BiotechDeep Tech

Dr. Srinivas Akkaraju(Founder and Managing General Partner)

Co-investorsMOModi Ventures

Sensulin is a preclinical biopharmaceutical company developing glucose-responsive insulin therapies for type 1 and type 2 diabetes that aim to reduce hypoglycemia risk and daily injection requirements.

BiotechMedical Devices

DBDan Bradbury(Executive Chairman and Co-Founder)inMMMike Moradi(CEO)in

BoardAnanth AnnapragadainChristopher Rhodesin

Co-investorsCOCortado Ventures

Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age.

ConsumerLongevityWellness & Fitness

SVStephanie Venn-Watson(Founder)in

Co-investors131315 Capital

Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix.

BiotechDeep TechHealthtech

Robert O. Baratta(Co-founder)SDShawn DeLorey(Operations & Corporate Development (inventor of PolyCol))in

A company offering regenerative and aesthetic medical products for facial, breast, and body treatments across all stages of life.

HealthtechMedical DevicesSan Diego, US

Nicholas L. Teti, Jr.(Executive Officer, Director)Joseph A. Newcomb(Executive Officer)Stewart M. Brown(Executive Officer)in

BoardClarke B. Futch(Director)Paul J. Hadden(Director)Todd C. Davis(Director)

Co-investorsESEssex Woodlands Healthcare PartnersHEHEALTHCARE ROYALTY PARTNERSPOPolaris Partners

Tocagen is a clinical-stage biotechnology company developing cancer-selective gene therapies designed to activate a patient's immune system against their own cancer.

BiotechHealthtechSan Diego, US

Harry Gruber(Executive Officer, Director)Thomas Darcy(Executive Officer, Director)Dennis Berman(Executive Officer, Director)Douglas Jolly(Executive Officer)

BoardFaheem Hasnain(Director)Lori Kunkel(Director)